Please provide your email address to receive an email when new articles are posted on . A novel SK ion channel inhibitor more often converted atrial fibrillation to sinus rhythm compared with placebo.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Artificial intelligence accurately predicted atrial ...

San Diego, CA - A substudy of the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial indicates that amiodarone is the most effective drug in terms of keeping patients ...

March 5, 2004 — The results of a substudy from the Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) trial find that patients with persistent atrial fibrillation ...

The analysis compared patients who received rhythm-control therapy for the treatment of new-onset AF to those who did not. Among critically ill patients with sustained new-onset atrial fibrillation ...

Sinus arrhythmia is the variation in heart rate attributable to respiration. Fox and Forges (1985) have found that the “amplitude” of sinus arrhythmia measured near birth is correlated with ...

DEAR DR. ROACH: I am an active 76-year-old man. I became aware of an increase in my resting heart rate in April 2021, going from a resting rate of 48 to 74 beats per minute in a six-day period. It is ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

XYRA gets US patent protecting use of dose adjusted budiodarone to treat AF, with monitoring to correspondingly reduce/delay risk of stroke and/or congestive heart failure: Los Al ...

Human heart and its electrical system, 3d illustration. The yellow lines demonstrate the electrical (conduction) system of the heart. The heart at right shows an irregular heartbeat (arrhythmia) and ...